The Journal of Immunology · 1976 · 228 citations · 0 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyTumor ImmunologyAntitumor T Cell ResponsesImmunosuppressionImmunosuppressive TherapyT Cell Responses To TumorsTumor-associated AntigensTumor-infiltrating LymphocytesBone Marrow - Derived CellsCancer-associated ImmunosuppressionImmunosuppressive CompoundsImmunosuppressive FunctionT-cell Responses To Tumor Antigens
Abstract A/Jax mice were rendered immune to the syngeneic and transplantable methylcholanthrene-induced Sarcoma 1509a by the surgical removal of the tumor 7 days after implantation; subsequent injection of tumor cells resulted in their rejection within 15 days. The i.v. transfer of 107 to 108 washed thymus or spleen cells of tumor-bearing animals (TBA) to immune animals significantly inhibited the rejection of the tumor; this suppressive effect was entirely abolished by the treatment of these lymphocytes with anti-θ serum or anti-thymocyte serum (ATS) and complement before adoptive transfer. On the other hand, an equal number of thymus or spleen cells of normal animals or of animals bearing an unrelated tumor had no suppressive effect. Treatment of normal syngeneic animals with ATS after tumor cell inoculation or splenectomy of TBA resulted in the suppression of the tumor growth. The serum of TBA had no effect on tumor growth in immune syngeneic mice. Together these results suggest that TBA possess immunosuppressor T cells regulating negatively their immune response to the tumor.